Clinical Trial Update: Controlled Clinical Trial of Antiviral Cytotoxic T Lymphocyte (CTL) Infusion Following Combination Antiretroviral Drug Therapy for Asymptomatic HIV-1 Infection [NA]

View source ↗

Summary

A controlled clinical trial evaluating cytotoxic T lymphocyte (CTL) infusion after combination antiretroviral therapy for asymptomatic HIV-1 infection has been …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Cytotoxic T lymphocyte infusion

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | NA | Status: TERMINATED